MEETINGS - Drug/Device and Device/Drug Combinations (UK) September 2006:
This article was originally published in Clinica
Drug/Device and Device/Drug Combinations, a Management Forum event targeted at development and regulatory personnel, will take place on September 12-13 2006 at Harrington Hall Hotel, Harrington Gardens, London, UK. Cell therapy and tissue-engineered products combined with pharmaceuticals and medical devices will also be considered. For details and to register, contact: Management Forum, 98-100 Maybury Road, Woking GU215JL UK. Tel: +44(0)1483 730071; fax: +44(0)1483 730008; email: email@example.com www.management-forum.co.uk
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.